Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease | Zendy

Hung Fu Tseng | Zendy; Yi Luo | Zendy; Jiaxiao Shi | Zendy; Lina S. Sy | Zendy; Sara Y. Tartof | Zendy; John J. Sim | Zendy; Rulin C. Hechter | Zendy; Steven J. Jacobsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease

Author(s) -

Hung Fu Tseng,

Yi Luo,

Jiaxiao Shi,

Lina S. Sy,

Sara Y. Tartof,

John J. Sim,

Rulin C. Hechter,

Steven J. Jacobsen

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ930

Subject(s) - medicine , hazard ratio , vaccination , incidence (geometry) , proportional hazards model , cumulative incidence , cohort , end stage renal disease , population , confidence interval , dialysis , cohort study , pediatrics , disease , immunology , physics , environmental health , optics

Unlike in a healthy population, the protection of herpes zoster (HZ) vaccine in end-stage renal disease (ESRD) patients might be insufficient, considering data demonstrating suboptimal response to other vaccines. The study evaluates the association between HZ vaccination and the subsequent HZ risk among ESRD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research